UK-414,495
A phosphodiesterase inhibitor
UK-414,495 is a chemical compound that functions as a phosphodiesterase type 5 (PDE5) inhibitor. It was developed for the potential treatment of erectile dysfunction (ED) and other conditions related to PDE5 inhibition.
Mechanism of Action[edit | edit source]
UK-414,495 works by selectively inhibiting the enzyme phosphodiesterase type 5 (PDE5). PDE5 is responsible for the breakdown of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. By inhibiting PDE5, UK-414,495 increases the levels of cGMP, leading to smooth muscle relaxation and increased blood flow to the penis, facilitating an erection.
Development and Research[edit | edit source]
UK-414,495 was developed as part of research into new treatments for erectile dysfunction. The compound was studied for its potential to provide an alternative to existing PDE5 inhibitors such as sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra). However, like many investigational drugs, it did not progress to market.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of UK-414,495 includes its absorption, distribution, metabolism, and excretion. As a PDE5 inhibitor, it is expected to be absorbed into the bloodstream and distributed to tissues where PDE5 is present. The metabolism of UK-414,495 would likely involve hepatic pathways, similar to other PDE5 inhibitors, and it would be excreted primarily through the urine.
Potential Uses[edit | edit source]
While UK-414,495 was primarily investigated for the treatment of erectile dysfunction, PDE5 inhibitors have also been explored for other medical conditions. These include pulmonary arterial hypertension, where PDE5 inhibition can lead to vasodilation in the pulmonary vasculature, and Raynaud's phenomenon, where increased blood flow can alleviate symptoms.
Safety and Side Effects[edit | edit source]
As with other PDE5 inhibitors, potential side effects of UK-414,495 could include headache, flushing, dyspepsia, and nasal congestion. Serious side effects might include hypotension, priapism, and visual disturbances. The safety profile would need to be thoroughly evaluated in clinical trials.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
